Literature DB >> 3106525

Structure and activity of glycosylated human interferon-gamma.

T Arakawa, Y R Hsu, D Chang, N Stebbing, B Altrock.   

Abstract

Structural properties and activity of recombinant human interferon-gamma (IFN-gamma) purified from Chinese hamster ovary (CHO) cells or a natural source were determined and compared with those of Escherichia coli-derived IFN-gamma. One preparation of CHO-derived IFN-gamma showed three bands, with the middle band being a doublet, in a SDS-polyacrylamide gel. The two higher-molecular-weight bands were shown to be glycosylated. Western blot analysis indicated that the three bands are IFN-gamma and lack an intact carboxyl terminus. The circular dichroic (CD) spectra showed that conformation of the CHO-derived IFN-gamma is similar in the native state, in acid, and after renaturation from acid to the E. coli-derived IFN-gamma. These results indicate that neither glycosylation nor carboxy-terminal processing affects conformational properties of the protein, as detected by CD spectroscopy. However, the antiviral activity was fourfold lower for the preparation of CHO-derived IFN-gamma than for the E. coli-derived IFN-gamma. A different preparation or a natural IFN-gamma preparation with less extensive carboxy-terminal processing showed similar conformational properties and antiviral activity to the E. coli-derived IFN-gamma. These results indicate that the carboxyl terminus, but not glycosylation, plays an important role in the antiviral activity of IFN-gamma.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3106525     DOI: 10.1089/jir.1986.6.687

Source DB:  PubMed          Journal:  J Interferon Res        ISSN: 0197-8357


  5 in total

1.  Source of heterogeneity in secreted interferon-gamma. A study on products of translation in vitro.

Authors:  N J Bulleid; E Curling; R B Freedman; N Jenkins
Journal:  Biochem J       Date:  1990-06-15       Impact factor: 3.857

2.  Transfected Plasmodium knowlesi produces bioactive host gamma interferon: a new perspective for modulating immune responses to malaria parasites.

Authors:  Hastings Ozwara; Jan A M Langermans; Clemens H M Kocken; Annemarie van der Wel; Peter H van der Meide; Richard A W Vervenne; Jason M Mwenda; Alan W Thomas
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

3.  Application of a wide-range yeast vector (CoMed) system to recombinant protein production in dimorphic Arxula adeninivorans, methylotrophic Hansenula polymorpha and other yeasts.

Authors:  Gerhard Steinborn; Erik Böer; Anja Scholz; Kristina Tag; Gotthard Kunze; Gerd Gellissen
Journal:  Microb Cell Fact       Date:  2006-11-14       Impact factor: 5.328

4.  Increasing affinity of interferon-γ receptor 1 to interferon-γ by computer-aided design.

Authors:  Pavel Mikulecký; Jiří Cerný; Lada Biedermannová; Hana Petroková; Milan Kuchař; Jiří Vondrášek; Petr Malý; Peter Šebo; Bohdan Schneider
Journal:  Biomed Res Int       Date:  2013-10-02       Impact factor: 3.411

5.  Systematic evaluation of monoclonal antibodies and immunoassays for the detection of Interferon-γ and Interleukin-2 in old and new world non-human primates.

Authors:  Ankie Höglind; Irene Areström; Cecilia Ehrnfelt; Khosro Masjedi; Bartek Zuber; Luis Giavedoni; Niklas Ahlborg
Journal:  J Immunol Methods       Date:  2016-11-24       Impact factor: 2.303

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.